Tested samples | Median inhibitory concentrations, parameters of the model and exposure time | |||||
---|---|---|---|---|---|---|
24 h | 72 h | |||||
IC50a (% v/v, μl) | 95% CIb | R | IC50 (% v/v, μl) | 95% CI | Rc | |
Solvents | ||||||
XXGly | 1.180 | 0.985–1.412 | 0.904 | 1.394 | 1.261–1.542 | 0.950 |
CAPD | 0.089 | 0.075–0.105 | 0.940 | 0.141 | 0.126–0.158 | 0.971 |
XXGIH | 0.077 | 0.043–0.139 | 0.980 | 0.096 | 0.085–0.108 | 0.964 |
XXPD | 2.677 | 1.516–4.611 | 0.906 | 1.503 | 1.197–1.887 | 0.707 |
Extracts | ||||||
XXGly/S | 0.803 | 0.563–1.148 | 0.952 | 0.589 | 0.391–0.886 | 0.901 |
XXGly/P | 1.267 | 0.957–1.679 | 0.912 | 1.094 | 0.845–1.418 | 0.894 |
CAPD/S | 0.046 | 0.040–0.054 | 0.955 | 0.148 | 0.136–0.161 | 0.971 |
CAPD/P | 0.045 | 0.039–0.053 | 0.956 | 0.024 | 0.021–0.027 | 0.962 |
IC50 (µg/ml tPd) | 95% CI | R | IC50 (µg/ml tP) | 95% CI | R | |
---|---|---|---|---|---|---|
Extracts | ||||||
XXGly/S | 12.212 | 8.550–17.450 | 0.952 | 8.953 | 5.941–13.490 | 0.901 |
XXGly/P | 15.711 | 11.863–20.820 | 0.912 | 13.566 | 10.470–17.590 | 0.894 |
CAPD/S | 0.046 | 0.040–0.054 | 0.955 | 0.148 | 0.136–0.161 | 0.971 |
CAPD/P | 4.607 | 4.026–5.376 | 0.956 | 0.243 | 0.210–0.275 | 0.962 |